These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9814686)
1. Significance of IgA antiphospholipid antibodies. Wilson WA; Faghiri Z; Taheri F; Gharavi AE Lupus; 1998; 7 Suppl 2():S110-3. PubMed ID: 9814686 [TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
3. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome. Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to cardiolipin and beta2-glycoprotein-1 in HTLV-1-associated myelopathy/tropical spastic paraparesis. Faghiri Z; Wilson WA; Taheri F; Barton EN; Morgan OS; Gharavi AE Lupus; 1999; 8(3):210-4. PubMed ID: 10342713 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Samarkos M; Davies KA; Gordon C; Loizou S Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus. Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508 [TBL] [Abstract][Full Text] [Related]
10. IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus. Cucurull E; Gharavi AE; Diri E; Mendez E; Kapoor D; Espinoza LR Am J Med Sci; 1999 Jul; 318(1):55-60. PubMed ID: 10408762 [TBL] [Abstract][Full Text] [Related]
11. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Carmo-Pereira S; Bertolaccini ML; Escudero-Contreras A; Khamashta MA; Hughes GR Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291 [TBL] [Abstract][Full Text] [Related]
12. Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus. Lee SS; Cho ML; Joo YS; Kim WU; Hong YS; Min JK; Lee SH; Park SH; Cho CS; Kim HY J Rheumatol; 2001 Mar; 28(3):520-4. PubMed ID: 11296952 [TBL] [Abstract][Full Text] [Related]
13. The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies: a systematic review. Meijide H; Sciascia S; Sanna G; Khamashta MA; Bertolaccini ML Autoimmun Rev; 2013 Jan; 12(3):421-5. PubMed ID: 22951216 [TBL] [Abstract][Full Text] [Related]
14. Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype. Lakos G; Kiss E; Regëczy N; Tarján P; Soltész P; Zeher M; Bodolay E; Szakony S; Sipka S; Szegedi G Clin Exp Immunol; 1999 Sep; 117(3):574-9. PubMed ID: 10469065 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels. Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204 [TBL] [Abstract][Full Text] [Related]
16. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME; Cabiedes J; Reyes E; Cabral AR Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus. Toschi V; Motta A; Castelli C; Gibelli S; Cimminiello C; Molaro GL; Gibelli A Haemostasis; 1993; 23(5):275-83. PubMed ID: 8175049 [TBL] [Abstract][Full Text] [Related]
19. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748 [TBL] [Abstract][Full Text] [Related]
20. Anti beta2-glycoprotein I antibodies: clinical significance. Tincani A; Spatola L; Cinquini M; Cattaneo R; Meroni P; Balestrieri G Lupus; 1998; 7 Suppl 2():S107-9. PubMed ID: 9814685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]